Surveillance

Hospital-Wide Healthcare-associated Bloodstream Infections : surveillance results 2014–2015

Hospital-Wide Healthcare-associated Bloodstream Infections
Surveillance results: 2014-2015

From April 1st, 2014, to March 31st, 2015, 88 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,733,772 patient-days (Table 1). Participating facilities reported 3,035 BSIs in 2,832 patients. The total incidence rate was 5.3 cases per 10,000 patient-days. The incidence rate in 2014–2015 was significantly lower compared to the average rate for 2010–2014 in facilities that took part in both surveillance periods. Two teaching and 10 non-teaching facilities joined the program in 2014–2015 and one stopped participating; in addition, four facilities are not counted anymore in the 2013-2014 surveillance results, having provided data for less th…

Surveillance provinciale des infections nosocomiales

Clostridium difficile–Associated Diarrhea (CDAD) : surveillance results 2014–2015

Clostridium difficile–Associated Diarrhea (CDAD)
Surveillance Results: 2014-2015

From April 1, 2014, to March 31, 2015, 95 healthcare facilities participated in the surveillance of Clostridium difficile–associated diarrhea (CDAD), for a combined total of 5,076,655 inpatient days (Table 1). The participating facilities reported 3,453 cases of healthcare-associated (HA) CDAD. The incidence rate of HA CDAD was 6.8 cases per 10,000 patient days. This incidence rate was significantly lower compared to the rate of 2013–2014. The 10-day fatality rate was 9.8% (n = 285) while the 30-day fatality rate was 18.6% (n = 543). In total, 36 (1.2%) colectomies were reported. Data was extracted on May 20th, 2015 and updated on June 1st 2015.  

Updated : March 24…

Surveillance provinciale des infections nosocomiales

Vancomycin-Resistant Enterococci (VRE) Infections : surveillance results 2014–2015

Vancomycin-Resistant Enterococci (VRE) Infections
Surveillance results: 2014-2015

From April 1, 2014, to March 31, 2015, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,839,578 patient days (Table 1). In total, 87 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a + 1b). The incidence rate of healthcare-associated VRE infections (cat. 1a + 1b) was 0.18 / 10,000 patient days. This incidence rate was stable since 2013-2014. The acquisition rate of healthcare-associated VRE colonization (cat. 1a + 1b) was 10.99 / 10,000 patient days. Data was extracted on May 20th, 2015 and updated on June 1, 2015 for complications.

Surveillance provinciale des infections nosocomiales

Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections : surveillance results 2014–2015

Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections
Surveillance results: 2014–2015

From April 1, 2014, to March 31, 2015, 88 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,689,050 inpatient days (Table 1). Together, these facilities reported 95 cases of healthcare-associated MRSA. The incidence rate was 0.20 / 10,000 patient-days. This incidence rate has declined over the past five years but has stabilized this year. The proportion of methicillin resistance in healthcare-associated S. aureus bloodstream infections was 17.8%. Data was extracted on May 20th, 2015 and updated on June 1st 2015 for complications

Update…

Surveillance provinciale des infections nosocomiales

Prevalence of Hypertension in Québec: A Comparison of Health administrative Data and Survey Data

Among the risk factors for cardiovascular disease, hypertension is the leading factor since 13% of deaths overall are attributed to it. Given the considerable weight of this risk factor from the standpoint of public health, it is necessary that population-based studies be conducted to measure its prevalence and evolution over time. In Québec, the universal healthcare system is administered, among other things, by means of health administrative databases that are constantly being updated and can be linked. Population-based health surveys are conducted on a regular basis and provide other types of data. The data collected through the surveys can be self-reported or measured. The main objective of this study is to compare the prevalence of estimated hypertension based on three data sources: 1) linked health administrative data; 2) self-reported data from the Canadian Community Health Survey (CCHS); and 3) measured data from the Canadian Health Measures Survey (CHMS).

Monitoring of Alzheimer’s Disease and Related Disorders: Feasibility Study Based on Health Administrative Databases

The term dementia refers to a group of degenerative diseases that affect cognitive function and lead to loss of functional autonomy. Vascular dementia and Alzheimer’s disease (AD) are the most common forms of dementia. In this report, the term “Alzheimer’s disease and related disorders” will be used.

Alzheimer’s disease and related disorders generally start appearing from the age of 60 to 65 years of age and onwards. They affect individuals’ daily functioning by disrupting their memory, judgment, organization, orientation, language or control over their behaviour and emotions. These diseases place a staggering burden on individuals who are affected, their families and caregivers, as well as on professionals and the health system.

To date, most estimates of the prevalence and incidence of AD and related disorders in Canada are still based on the Canadian Study of Health and Aging (CSHA), a large population study conducted across Canada between 1991 a…

Surveillance of Personality Disorders in Québec: Prevalence, Mortality, and Service Utilization Profile

The aim of this report is to describe the use of administrative databases to estimate the prevalence of diagnosed group B personality disorders, along with service utilization and mortality. This group will be compared to personality disorders outside of group B and to serious or common psychiatric conditions (schizophrenia, anxio-depressive disorders) concerning which the INSPQ has already published.

Group B personality disorders represent a common psychiatric condition. Their mortality rate classifies them among chronic disorders, both psychiatric and physical, with very high case fatality (Lesage et al., 2012; Lesage et al., 2015). Moreover, and notably, the excess mortality associated with this psychopathology does not take into account the psychological suffering experienced by the persons afflicted, or their relatives, or the impact experienced on the level of psychosocial functioning. The severity of this psychiatric condition quite evidently influences the…

Highlights, Discussions and Orientations 2012-2013 : Healthcare-Associated Infections Provincial Surveillance Program

The ministère de la Santé et des Services sociaux (MSSS) mandated the Institut national de santé publique du Québec (INSPQ) with the provincial surveillance of healthcare-associated infections (HAI), as outlined in the 2003–2012 Programme national de santé publique (Public Health Plan), revised in 2008 as well as in the 2006–2009 and 2010–2015 versions of the Plan d’action sur la prévention et le contrôle des infections nosocomiales (Action Plan for Preventing and Controlling HAIs) aimed at reducing the transmission of HAIs in Québec’s healthcare facilities.

The INSPQ set up a structured surveillance program to support public health administrations and local infection prevention and control teams in general and specialized healthcare facilities. The program includes a set of standardized tools and educational activities focusing on infections categorized as “priorities” by the MSSS and by the INSPQ’s Comité des infections nosocomiales du Québec (CINQ) and the Groupe de trava…

Surveillance provinciale des infections nosocomiales

Integrated West Nile Virus Surveillance

A new government intervention plan was adopted in early 2013 to protect public health against West Nile virus (WNV) infection, since WNV infection epidemiological activity had resumed in Québec in 2011 and 2012. This new plan establishes the strategy to be pursued for the years 2013 to 2015. The primary objective of the strategy adopted by public health authorities is to prevent the complications and human mortality related to WNV infection.

Interventions are planned to combat the WNV vector, namely mosquitoes. The intervention plan also includes communication activities aimed at the general public and health care and social services network professionals. An integrated surveillance program was set up in 2013 to continue monitoring the situation. This program allows us to characterize WNV activity in Québec in humans and animals.

This analysis plan was prepared by the Institut national de santé publique du Québec's Groupe d'experts scientifiques sur le VNO [WNV…

West Nile Virus Infection Surveillance in Québec: 2013 Season

In 2013, integrated surveillance of West Nile virus (WNV) in Québec included epidemiological surveillance of human cases, entomological surveillance of mosquitoes and surveillance of animals, including wild birds and domestic animals (agricultural).

During this season, 30 human cases of WNV infection were acquired in Québec, including 29 confirmed cases and one probable case. Of these, 23 (77%) were classed as WNV neuroinvasive cases and 22 were hospitalized, including eight people who were admitted to intensive care and one person who died of meningitis caused by WNV.

The average age of cases was 59 years and two thirds of the cases were men (20/30). More than 70% of the human cases occurred in the Montérégie, Montréal and Laval regions. Of the reported animals that were confirmed positive, nearly 66% were found in these same regions. A total of 2,530 mosquito pools were tested for WNV in 2013, and 60 pools (2.4%) tested positive.

In…